U.S. Physical Therapy, Inc. operates in the healthcare sector through two primary business segments: physical therapy operations and industrial injury prevention (IIP). The physical therapy segment provides outpatient and home-care services, including physical, speech, and occupational therapy, focusing on pre- and post-operative care, orthopedic disorders, sports injuries, and worker rehabilitation. The company serves patients through a network of clinics in 44 states, primarily in the United States, utilizing a partnership model where it acts as the general partner or managing member alongside local healthcare practitioners. The IIP segment offers onsite services to employers, including injury prevention, ergonomic assessments, functional capacity evaluations, and performance optimization, with a client base that includes Fortune 500 companies. The company was re-incorporated in 1992 and has been supporting private practice partnerships since 1990. It generates revenue through per-procedure billing, Medicare standards, and management fees from hospital and physician-owned practices. Key subsidiaries include MSO Metro LLC and Briotix Health Limited Partnership.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Care Facilities Homepage usph.com
Sector Healthcare IR page usph.com/investor-relations
Tags
physical therapy, occupational therapy, speech therapy, outpatient care, home health, injury prevention, ergonomics, workers compensation, rehabilitation, management services, MSO Metro LLC, Briotix Health Limited Partnership
Press page usph.com/press-releases

Metrics

Valuation  
Market cap $ 1.484B
Market cap (USD) $ 1.484B
P/E 102.49
PEG 14.29
P/BV 3.46
P/S 1.77
P/OCF 16.71
P/FCF 21.48
Dividend yield 1.8%
Turnover / mcap —
Returns  
ROE 8.2%
ROI 6.2%
ROIC 10.1%
Profit margin 5.1%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 7.2%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 57.3%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 32
Quality score 22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 780.99M 671.345M 604.802M 553.144M 495.022M 422.969M 481.969M 453.911M 414.051M 356.546M 331.302M 305.074M 264.058M 252.088M 237.006M 211.233M — — — — — — 105.568M 94.739M 80.948M 63.222M
Net profit 39.583M 31.424M 28.239M 32.158M 40.831M 35.194M 40.039M 34.873M 22.256M 20.551M 22.279M 20.853M 12.723M 17.933M 20.974M 15.645M 19.974M 10.004M 8.738M 6.296M 8.791M 6.678M 7.331M 8.488M 7.071M 3.735M
Free cash flow 60.987M 65.754M 72.684M 50.289M 68.205M 92.356M 52.259M 65.812M 49.431M 42.79M 34.98M 40.027M 40.158M 35.015M 29.433M 26.848M 27.068M 25.873M 15.013M 13.817M 13.725M 12.914M 12.399M 13.959M 11.828M 6.034M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 78.09 88.71 93.14 81.03 95.55 120.25 114.35 102.35 72.2 70.2 53.68 41.96 35.26 27.53 20.16 19.41 15 9.61 — 12.07 — — — — — —
Price performance 12m -0.12 -0.05 0.15 -0.15 -0.21 0.05 0.12 0.42 0.03 0.31 0.28 0.19 0.28 0.37 0.04 0.29 0.56 — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 38.8M 44.7M 44.8M 46.2M 41.9M 46.3M 51.9M 51.9M 59M 64.2M
↳ YoY growth +7.2% +15.1% +0.1% +3.3% -9.3% +10.4% +12.2% -0.1% +13.8% +8.8%
↳ 5y CAGR +7.0% +3.0% +3.6% +3.0% +3.0% +5.0% +8.9%
Borrowings, current (USD) 1.23M 4.04M 1.43M 728,000 4.9M 830,000 7.86M 7.69M 11M 9.87M
Borrowings, non-current (USD) 50.6M 56.7M 38.4M 50.4M 16.6M 118M 176M 139M 143M 153M
Lease liabilities (USD) — — 0.00 86.7M 89.5M 105M 112M 112M 142M 153M
Cash and deposits (USD) 20M 21.9M 23.4M 23.5M 32.9M 28.6M 31.6M 153M 41.4M 35.6M
Intangible assets (USD) 38.1M 49M 48.8M 52.6M 56.3M 86.4M 109M 110M 179M 173M
Right-of-use assets (USD) — — 0.00 81.6M 81.6M 96.4M 103M 103M 134M 144M
Net debt (borrowings + leases - cash) (USD) 31.8M 38.8M 16.5M 114M 78.1M 195M 264M 106M 254M 280M
Cash flow detail
Operating cash flow (USD) 51.1M 56.5M 73M 62.4M 100M 76.4M 58.5M 82M 74.9M 75.1M
Purchases of property, plant and equipment (USD) -8.26M -7.1M -7.19M -10.2M -7.64M -8.2M -8.25M -9.29M -9.19M -14.1M
Change in receivables (cash effect) (USD) -3.28M -3.45M -3.43M -6.38M 899,000 -9.42M -10.3M -5.65M -5.35M -12M
Change in payables (cash effect) (USD) 2.99M 6.98M 4.88M -4.21M 12.4M 4.66M -7.76M 15,000 1.71M -7.8M
Dividends paid (cash effect) (USD) -8.51M -10.1M -11.7M -14.6M -4.11M -18.8M -21.3M -24.1M -26.5M -27.4M
Share buybacks (cash effect) (USD) — — — — — — — 0.00 0.00 -5.57M
Interest paid (cash effect) (USD) -784,000 -2.11M -2.36M -1.89M -1.2M -1.35M -5.69M -8.66M -7.21M -9.43M
Income taxes paid (cash effect) (USD) -10.6M -8.54M -9.18M -9.86M -7.68M -12.2M -7.62M -4.93M -4.83M -14.3M
Share-based compensation (USD) 4.96M 5.03M 5.94M 6.99M 7.92M 7.87M 7.26M 7.24M 7.82M 8.27M
Operating cash flow before change in receivables (USD) 54.3M 60M 76.4M 68.8M 99.1M 85.8M 68.8M 87.6M 80.3M 87M
Free cash flow (OCF - PPE - intangibles) (USD) 42.8M 49.4M 65.8M 52.3M 92.4M 68.2M 50.3M 72.7M 65.8M 61M
Income detail
Total comprehensive income (USD) — — — — 52.5M 57.9M 47.4M 36M 45.6M 55.9M
Comprehensive income to owners (USD) — — — — 35.2M 40.8M 36.2M 27M 31.4M 37.5M
Provision for credit losses (USD) 4.04M 3.67M 4.6M 4.86M 4.62M 5.31M 5.55M 6.17M 6.91M 7.65M
Credit cost ratio (credit losses / average receivables) (%) 10.8% 8.8% 10.3% 10.7% 10.5% 12.0% 11.3% 11.9% 12.5% 12.4%
Reported Jun 7, 2017 Mar 14, 2018 May 6, 2019 Feb 28, 2020 Feb 28, 2023 Feb 28, 2023 Feb 28, 2023 Feb 27, 2026 Feb 27, 2026 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Three Part Advisors Bull 0 Bear 1 Results

Joe Noyons

(817) 778-8424

USPH Reports Third Quarter 2026 Results,

Record High Visits and Revenue Per Visit

Houston, TX, November 4, 2026 – U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (“IIP”), today reported results for the three and nine months ended September 30, 2026.

• Total net revenue was $223 million for the third quarter ended September 30, 2026 (“Q3 2026”), a 13% increase over the third quarter ended September 30, 2025 (“Q3 2025”).

• Net income attributable to USPH shareholders was $11 million for Q3 2026 compared to $13 million for Q3 2025. The Company reported loss per share of $1.04 in Q3 2026 compared to earnings per share of $0.48 in Q3 2025. Included in pretax income for Q3 2026 was a $0.1 million loss on change in fair value of contingent earn out consideration compared to a gain of $6 million in Q3 2025.

Prompts

U.S. Physical Therapy, Inc. (ticker USPH), listed in United States.

ETFs Holding U.S. Physical Therapy, Inc.

ETF Weight in ETF Shares Market value As of
SOVF 2.05% 22,695 $ 1.794M Jul 31, 2026
SMLL 2.00% 2,726 $ 271.51K Nov 13, 2026
RUSC 0.32% 3,731 $ 256.245K Jun 30, 2026
ESSC 0.28% 1,270 $ 100.406K Jul 31, 2026
PSC 0.06% 20,392 $ 1.401M Jun 30, 2026
DFAT 0.04% 143,700 $ 14.169M Nov 12, 2026
SMDX 0.04% 515 $ 51.268K Nov 17, 2026
DFAS 0.03% 104,934 $ 10.346M Nov 12, 2026
MSSM 0.01% 1,353 $ 105.182K Aug 31, 2026
DXUV 0.01% 7,224 $ 712.286K Nov 12, 2026
DFAC 0.01% 75,889 $ 7.483M Nov 12, 2026
DFUV 0.01% 9,068 $ 894.105K Nov 12, 2026
DFSU 0.01% 1,245 $ 122.757K Nov 12, 2026
DCOR 0.00% 21,384 $ 2.108M Nov 12, 2026
DFAU 0.00% 4,165 $ 410.669K Nov 12, 2026
DFUS 0.00% 5,673 $ 559.358K Nov 12, 2026
EBI 0.00% 50 $ 3,887.00 Aug 31, 2026